Beating the Big C
Pharmaceutical Technology
JULY 23, 2008
.” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” ” “Companies can charge high prices for cancer drugs because there’s so much need for them and, within reason, governments are willing to pay for them as there is a clear surgical benefit from them,” says Ando.
52 
Let's personalize your content